Date: Tuesday, September 23, 2025
Time: 9am – 5pm
Location: Crowne Plaza Shanghai Jinxiu
Certainty by Certara offers exclusive access to industry leaders and clinical researchers with opportunities to achieve better certainty in drug development through the presentations related to Model-informed Drug Development, clinical pharmacology, QSP, PBPK, and more.
You can learn case studies and the latest scientific trends from our special guest speakers and Certara’s experts and ask questions directly. We hope this annual event will help you connect with innovative researchers from various pharmaceutical companies and bring the innovations to your team.
- Date & Time: 9:00 – 17:00, Tue, September 23rd
- Venue: Crowne Plaza Shanghai Jinxiu
- Registration fee: Free of charge
Agenda
Coming soon. You can find the preliminary list of confirmed speakers and their session titles. This page will be updated regularly as new details are confirmed.
Register now
Executive Director, Clinical Pharmacology, Abbisko Therapeutics Co., Ltd
Session: (TBC) MIDD for early clinical development
Statistical Programming Senior Manager, Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Session: AI-Driven Dynamic Adaptive Clinical Programming Paradigm
VP, Global Head, Clinical Pharmacology & Translational Medicine Certara Drug Development Solutions
Session: Designing a High-Value Drug Development Program: From Concept to First-in-Human, Commercial Considerations for Early Development – Setting the Destination
Vice President, Head of QSP, Certara
Session: Translating QSP from Discovery to the Clinic: Applications, Regulatory Impact, and a Sneak Peek at Certara IQ
Associate Principal Scientist, Certara
Session: MBMA in Early-Phase Development: Optimizing Go/No-Go Decisions Through Quantitative Frameworks
Senior PBPK Consultant, Certara
Session: Bridging Knowledge Gaps: Quantified Success Stories in PBPK
Solution Consultant, Software, Certara
Session: The Certara Platform: Advanced Technology to Increase Certainty in Drug Discovery and Development
Register now
